Reports for SANOFI-AVENTIS CANADA INC
Formerly known as SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
Company Name
SANOFI-AVENTIS CANADA INC
Shortage reports
Actual shortage:
3 (1%)
Anticipated shortage:
0 (0%)
Avoided shortage:
16 (5%)
Resolved:
277 (94%)
296
Discontinuation Reports
To be discontinued:
8 (13%)
Discontinued:
53 (85%)
Reversed:
1 (2%)
62
21 (6%)
4 (36%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2022-08-11 | 2022-08-11 | 166530 |
| AVALIDE | 12.5MG 300MG | TABLET | Avoided shortage | 2022-04-14 | 2022-08-11 | 158890 |
| AVALIDE | 150MG 12.5MG | TABLET | Resolved | 2021-01-28 | 2021-03-20 | 132678 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-02-08 | 2019-03-02 | 75166 |
| AVALIDE | 12.5MG 150MG | TABLET | Resolved | 2025-11-27 | 2025-12-05 | 272585 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-05-08 | 2019-05-10 | 83440 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-07-16 | 2020-01-24 | 89482 |
| AVALIDE | 12.5MG 150MG | TABLET | Resolved | 2019-10-09 | 2020-01-24 | 95800 |
| AVAPRO | 300MG | TABLET | Resolved | 2019-07-16 | 2019-11-05 | 89476 |
| AVAPRO | 75MG | TABLET | Avoided shortage | 2021-02-16 | 2021-03-19 | 134199 |
| AVAPRO | 75MG | TABLET | Resolved | 2021-12-16 | 2022-08-20 | 151325 |
| AVAPRO | 150MG | TABLET | Resolved | 2019-10-09 | 2020-01-24 | 95797 |
| AVAPRO | 75MG | TABLET | Resolved | 2021-05-21 | 2021-06-19 | 139790 |
| AVAPRO | 150MG | TABLET | Resolved | 2022-01-21 | 2022-06-09 | 153358 |
| AVAPRO | 300MG | TABLET | Resolved | 2019-02-08 | 2019-03-29 | 75171 |
| AVAPRO | 75MG | TABLET | Resolved | 2020-04-07 | 2020-06-29 | 111392 |
| AVAPRO | 300MG | TABLET | Resolved | 2019-11-29 | 2020-01-24 | 100061 |
| AVAPRO | 300MG | TABLET | Resolved | 2020-03-12 | 2020-04-22 | 108533 |
| AVAPRO | 75MG | TABLET | Resolved | 2019-11-29 | 2020-02-05 | 100048 |
| AVAPRO | 300MG | TABLET | Resolved | 2021-12-02 | 2022-06-09 | 150376 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NOVAHISTINE DH | 10MG 1.7MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98377 |
| PEDIAPRED | 5MG | SOLUTION | Discontinued | 2023-09-28 | 2023-12-19 | 205412 |
| PHISOHEX | 3% | EMULSION | Discontinued | 2017-03-20 | 2017-03-20 | 3696 |
| PLAVIX | 300MG | TABLET | To be discontinued | 2019-12-11 | 2019-12-11 | 100941 |
| RENVELA | 0.8G | POWDER FOR SUSPENSION | Discontinued | 2024-10-04 | 2025-04-03 | 239433 |
| RENVELA | 800MG | TABLET | Reversed | 2025-03-31 | 2025-09-26 | 253680 |
| RENVELA | 2.4G | POWDER FOR SUSPENSION | Discontinued | 2024-10-04 | 2025-04-03 | 239436 |
| RIFADIN | 300MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134218 |
| RIFADIN | 150MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134215 |
| RIFATER | 300MG 120MG 50MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3688 |
| SECTRAL | 400MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3692 |
| SECTRAL | 200MG | TABLET | Discontinued | 2018-07-09 | 2018-09-07 | 54767 |
| SECTRAL | 100MG | TABLET | Discontinued | 2018-09-17 | 2018-10-03 | 61609 |
| TALWIN | 50MG | TABLET | Discontinued | 2020-11-09 | 2021-02-06 | 128146 |
| TALWIN | 50MG | TABLET | Discontinued | 2021-02-09 | 2021-02-09 | 133620 |
| TAXOTERE | 20MG | SOLUTION | Discontinued | 2018-02-23 | 2018-05-28 | 40870 |
| TAXOTERE | 80MG | SOLUTION | To be discontinued | 2018-06-27 | 2018-10-17 | 53064 |
| TUSSIONEX | 5MG 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-08-17 | 2017-08-22 | 19700 |
| TUSSIONEX | 5MG 10MG | SUSPENSION | Discontinued | 2019-11-11 | 2020-03-24 | 98368 |
| ZALTRAP | 100MG | SOLUTION | Discontinued | 2020-07-30 | 2020-07-30 | 121387 |